Director, Us Forecasting & Analytics– Vaccines & Immune Therapies
AstraZeneca
Wilmington, DE, United States
Hybrid - on average 3 days a week from the office
Us demand forecasting
Patient-based and market-based models
Scenario and sensitivity analyses
The Director of US Forecasting & Analytics for Vaccines & Immune Therapies at AstraZeneca is a senior role focused on demand forecasting and analytics within the US market. The position requires extensive experience in pharmaceutical commercial forecasting, particularly in vaccines, and offers a hybrid work environment
Job Summary
The Director, US Forecasting & Analytics is a senior commercial insights leader responsible for US demand forecasting and analytics across the V&I portfolio.
Lead US short-term and long-term demand forecasts (TRx, NBRx, volume, patients, revenue) for V&I assets using robust, patient-based and market-based models.
Provide leadership over forecasting-adjacent analytics, ensuring advanced analytics and insights are embedded into forecasting and business planning.
Matching Summary
Match Score: 85
The Director of US Forecasting & Analytics for Vaccines & Immune Therapies at AstraZeneca is a senior role focused on demand forecasting and analytics within the US market. The position requires extensive experience in pharmaceutical commercial forecasting, particularly in vaccines, and offers a hybrid work environment.
Skills & Requirements
Must-have
US demand forecasting
patient-based and market-based models
scenario and sensitivity analyses
integrate multiple data types
advanced analytics/ML approaches
modern analytics tooling and automation
Nice-to-have
AI and advanced automation
continuous improvement in forecasting
familiarity with immunization dynamics
change leadership
product mindset for forecasting
Key Requirements
Bachelor’s degree in quantitative, scientific, or business-related field
8+ years’ experience in US pharmaceutical commercial forecasting
Hands-on model ownership experience
Strong understanding of US market access and payer dynamics